Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 022016
Company: CUMBERLAND PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
VAPRISOL CONIVAPTAN HYDROCHLORIDE 20MG INJECTABLE; INJECTION Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/28/2007 ORIG-1 Approval Type 6 - New Indication (no longer used) STANDARD Letter (PDF)
Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022016s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022016_vaprisol_toc.cfm

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English